Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rezolute, Inc. Director's Dealing 2015

Jun 29, 2015

32362_dirs_2015-06-29_ebe835db-a036-40b6-8f60-40964ac0dfc5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2015-06-24

Reporting Person: Welch David F (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1766432 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrant to purchase Common Stock $1.89 2017-01-15 Common Stock (8334) Indirect
Warrant to purchase Common Stock $2.34 2017-03-31 Common Stock (96155) Indirect
Warrant to purchase Common Stock $2.50 2017-12-31 Common Stock (1081082) Indirect
Warrant to purchase Common Stock $2.50 2018-04-06 Common Stock (540541) Indirect

Footnotes

F1: LRFA, LLC owns shares of common stock and warrants to purchase shares of common stock of the Issuer. Dr. Welch is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock held by LRFA, LLC.